Lifedrink Company, Inc.

TSE:2585 Stock Report

Market Cap: JP¥118.8b

Lifedrink Company Balance Sheet Health

Financial Health criteria checks 4/6

Lifedrink Company has a total shareholder equity of ¥12.8B and total debt of ¥13.8B, which brings its debt-to-equity ratio to 107.8%. Its total assets and total liabilities are ¥32.3B and ¥19.5B respectively. Lifedrink Company's EBIT is ¥4.9B making its interest coverage ratio 67.5. It has cash and short-term investments of ¥3.4B.

Key information

107.8%

Debt to equity ratio

JP¥13.79b

Debt

Interest coverage ratio67.5x
CashJP¥3.43b
EquityJP¥12.80b
Total liabilitiesJP¥19.51b
Total assetsJP¥32.30b

Recent financial health updates

No updates

Recent updates

Lifedrink Company's (TSE:2585) Earnings Are Weaker Than They Seem

Nov 20
Lifedrink Company's (TSE:2585) Earnings Are Weaker Than They Seem

Slowing Rates Of Return At Lifedrink Company (TSE:2585) Leave Little Room For Excitement

Sep 16
Slowing Rates Of Return At Lifedrink Company (TSE:2585) Leave Little Room For Excitement

JP¥6,350 - That's What Analysts Think Lifedrink Company, Inc. (TSE:2585) Is Worth After These Results

Aug 18
JP¥6,350 - That's What Analysts Think Lifedrink Company, Inc. (TSE:2585) Is Worth After These Results

Lifedrink Company's (TSE:2585) Promising Earnings May Rest On Soft Foundations

May 22
Lifedrink Company's (TSE:2585) Promising Earnings May Rest On Soft Foundations

The Returns At Lifedrink Company (TSE:2585) Aren't Growing

Feb 29
The Returns At Lifedrink Company (TSE:2585) Aren't Growing

Financial Position Analysis

Short Term Liabilities: 2585's short term assets (¥12.2B) exceed its short term liabilities (¥7.9B).

Long Term Liabilities: 2585's short term assets (¥12.2B) exceed its long term liabilities (¥11.6B).


Debt to Equity History and Analysis

Debt Level: 2585's net debt to equity ratio (81%) is considered high.

Reducing Debt: Insufficient data to determine if 2585's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 2585's debt is well covered by operating cash flow (42.1%).

Interest Coverage: 2585's interest payments on its debt are well covered by EBIT (67.5x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 03:59
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lifedrink Company, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shun IgarashiDaiwa Securities Co. Ltd.
Seiichiro SamejimaIchiyoshi Research Institute Inc.
Taichi OtsukaMarusan Securities Co. Ltd.